178 related articles for article (PubMed ID: 8186065)
1. The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion.
Verhagen CA; Mattie H; Van Strijen E
Br J Clin Pharmacol; 1994 Feb; 37(2):193-7. PubMed ID: 8186065
[TBL] [Abstract][Full Text] [Related]
2. The effect of probenecid on the renal tubular excretion of benzylpenicillin.
Overbosch D; Van Gulpen C; Hermans J; Mattie H
Br J Clin Pharmacol; 1988 Jan; 25(1):51-8. PubMed ID: 3370192
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of renal tubular transport of methotrexate by probenecid.
Bourke RS; Chheda G; Bremer A; Watanabe O; Tower DB
Cancer Res; 1975 Jan; 35(1):110-6. PubMed ID: 1109785
[TBL] [Abstract][Full Text] [Related]
4. Probenecid effect on cefuroxime pharmacokinetics in calves.
Soback S; Ziv G; Kokue EI
J Vet Pharmacol Ther; 1989 Mar; 12(1):87-93. PubMed ID: 2704066
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and the effect of probenecid on the renal excretion mechanism of diprophylline.
Nadai M; Apichartpichean R; Hasegawa T; Nabeshima T
J Pharm Sci; 1992 Oct; 81(10):1024-7. PubMed ID: 1432614
[TBL] [Abstract][Full Text] [Related]
6. Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid.
Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Jaehde U; Reiter A; Naber KG; Rodamer M; Sörgel F
Br J Clin Pharmacol; 2010 Feb; 69(2):167-78. PubMed ID: 20233180
[TBL] [Abstract][Full Text] [Related]
7. Enantiomer-enantiomer interaction of a uricosuric antihypertensive diuretic (DBCA) in renal tubular secretion and stereoselective inhibition by probenecid in the cynomolgus monkey.
Nakano M; Higaki K; Kawahara S
Xenobiotica; 1993 May; 23(5):525-36. PubMed ID: 8342300
[TBL] [Abstract][Full Text] [Related]
8. Renal disposition of ceftazidime illustrated by interferences by probenecid, furosemide, and indomethacin in rabbits.
Carbon C; Dromer F; Brion N; Cremieux AC; Contrepois A
Antimicrob Agents Chemother; 1984 Sep; 26(3):373-7. PubMed ID: 6391371
[TBL] [Abstract][Full Text] [Related]
9. Competitive inhibition of renal tubular secretion of gemifloxacin by probenecid.
Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Drusano GL; Sörgel F
Antimicrob Agents Chemother; 2009 Sep; 53(9):3902-7. PubMed ID: 19564368
[TBL] [Abstract][Full Text] [Related]
10. Comparison of dose doubling with probenecid for sustaining serum cefuroxime levels.
Garton AM; Rennie RP; Gilpin J; Marrelli M; Shafran SD
J Antimicrob Chemother; 1997 Dec; 40(6):903-6. PubMed ID: 9462447
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of ceftazidime given alone and combination with probenecid to unweaned calves.
Soback S; Ziv G
Am J Vet Res; 1989 Sep; 50(9):1566-9. PubMed ID: 2679252
[TBL] [Abstract][Full Text] [Related]
12. Saturation of the tubular excretion of beta-lactam antibiotics.
Bins JW; Mattie H
Br J Clin Pharmacol; 1988 Jan; 25(1):41-50. PubMed ID: 3370191
[TBL] [Abstract][Full Text] [Related]
13. No effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in dogs.
Kim SH; Kim WB; Lee MG
Res Commun Mol Pathol Pharmacol; 1998 Jul; 101(1):85-92. PubMed ID: 9755846
[TBL] [Abstract][Full Text] [Related]
14. Renal clearance of temocillin in volunteers.
Overbosch D; van Gulpen C; Mattie H
Drugs; 1985; 29 Suppl 5():128-34. PubMed ID: 4029016
[TBL] [Abstract][Full Text] [Related]
15. Renal tubular secretion and effects of furosemide.
Odlind B; Beermann B
Clin Pharmacol Ther; 1980 Jun; 27(6):784-90. PubMed ID: 7379446
[TBL] [Abstract][Full Text] [Related]
16. Tubular mechanisms determining the urinary excretion of tritiated prostaglandin E2 in the anaesthetized rat.
Haylor J; Lote CJ; Towers JD
J Physiol; 1988 Sep; 403():1-14. PubMed ID: 3253420
[TBL] [Abstract][Full Text] [Related]
17. Renal handling of the monobactam azthreonam in healthy subjects.
Swabb EA; Sugerman AA; Frantz M; Platt TB; Stern M
Clin Pharmacol Ther; 1983 May; 33(5):609-14. PubMed ID: 6682362
[TBL] [Abstract][Full Text] [Related]
18. Coupling between renal tubular secretion and effect of bumetanide.
Odlind B; Beermann B; Lindström B
Clin Pharmacol Ther; 1983 Dec; 34(6):805-9. PubMed ID: 6641097
[TBL] [Abstract][Full Text] [Related]
19. Renal responses and pharmacokinetics of piretanide in humans: effect of route of administration, state of hydration and probenecid pretreatment.
Noormohamed FH; McNabb WR; Dixey JJ; Lant AF
J Pharmacol Exp Ther; 1990 Sep; 254(3):992-9. PubMed ID: 2395126
[TBL] [Abstract][Full Text] [Related]
20. Probenecid alters topotecan systemic and renal disposition by inhibiting renal tubular secretion.
Zamboni WC; Houghton PJ; Johnson RK; Hulstein JL; Crom WR; Cheshire PJ; Hanna SK; Richmond LB; Luo X; Stewart CF
J Pharmacol Exp Ther; 1998 Jan; 284(1):89-94. PubMed ID: 9435165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
